Skip to main content
. 2021 Mar 8;41(5):911–920. doi: 10.1007/s00296-021-04824-4

Fig. 1.

Fig. 1

Therapeutics considered for pediatric COVID-19. The number of respondents expressing their opinion on each treatment option is depicted in each line next to the drug name; number of respondents supporting the particular treatment is shown within the bars; their length reflects proportion of positive responses in case of the given treatment. For better comprehension, the treatment options are split into two main categories (anti-viral and immunomodulatory therapy), though the therapeutic effects might be overlapping. *prednisolone ≤ 2 mg/kg/d, **high-dose prednisolone (10–30 mg/kg/d)